Decitabine normalizes the demethylation status of cancer suppressor genes by inhibition of DNA methyltransferase-1 (DNMT1), as well as normalizing terminal differentiation, the aging process or apoptosis of cells. This evidence concerns the gene DNMT1 and cancer.